The drug is indicated to treat hypertension and had a market size of $81.9 million for the 12 months ended November 2016, according to QuintilesIMS data.
The drug is indicated to treat adults with chronic idiopathic constipation.
The drug has an estimated market size of $117 million for the 12 months ended November 2016, according to QuintilesIMS.
Alongside the availability announcement, kaléo unveiled its Auvi-Q access program, AffordAbility, through which patients with commercial insurance will have an out-of-pocket cost of $0.
Citron Research's analysis notes that Lannett is highly leveraged and dependent on three drugs for a bulk of its sales and that even modest price cuts to its biggest sellers would cause it to violate its debt covenants.
The study found that retrospective rebates, discounts and fees have increased from $67 billion in 2013 to $106 billion in 2015.
iMedicare has provided savings to 315,398 patients at more than 5,000 pharmacies, saving an average of $1,150 in prescription costs.
The drug, indicated for pain severe enough to require daily, around-the-clock, long-term opioid treatment and patients for whom alternative therapy is inadequate, is formulated with Teva’s proprietary abuse-deterrent technology.
The $960 million all-cash transaction is aimed at growing Lilly’s migraine pain management portfolio and will add a potential near-term launch to its late-stage pipeline.